These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5985262)

  • 21. Sensitivity to lysostaphin as a criterion for the identification of staphylococci from animal origin.
    Gutiérrez L; Menes I; Garcia ML; Moreno B
    J Appl Bacteriol; 1981 Jun; 50(3):541-9. PubMed ID: 7251519
    [No Abstract]   [Full Text] [Related]  

  • 22. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
    Warfield R; Bardelang P; Saunders H; Chan WC; Penfold C; James R; Thomas NR
    Org Biomol Chem; 2006 Oct; 4(19):3626-38. PubMed ID: 16990938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the antibacterial activity in vitro of 5-methyl-3-phenyl-4-isoxazolyl-penicillin and of other antibiotics and chemotherapeutic agents on strains of Micrococcus pyogenes var. aureus].
    Pierangeli L; Donati G; Villanti P; Calabrò R
    Boll Soc Ital Biol Sper; 1967 Jun; 43(12):704-5. PubMed ID: 6080722
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro anti-Gram-positive and antistaphylococcal biofilm activity of newly halogenated pyrroles related to pyrrolomycins.
    Schillaci D; Petruso S; Cascioferro S; Raimondi MV; Haagensen JA; Molin S
    Int J Antimicrob Agents; 2008 Apr; 31(4):380-2. PubMed ID: 18082373
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial activity of lysostaphin and a Listeria monocytogenes bacteriophage endolysin produced and secreted by lactic acid bacteria.
    Turner MS; Waldherr F; Loessner MJ; Giffard PM
    Syst Appl Microbiol; 2007 Jan; 30(1):58-67. PubMed ID: 16490333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.
    Cercenado E; Cercenado S; Gómez JA; Bouza E
    J Antimicrob Chemother; 2003 Jul; 52(1):138-9. PubMed ID: 12805264
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of pristamycin on staphylococci in vitro].
    Cybulska J; Jeljaszewicz J
    Med Dosw Mikrobiol; 1967; 19(3):219-24. PubMed ID: 6082376
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
    Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The antistaphylococcal activity of pristinamycin].
    Renzini G; Filadoro F; Monacelli E; Aurisicchio A
    Antibiotica; 1966 Jun; 4(2):125-34. PubMed ID: 5965436
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of resistance of Staphylococcus aureus to novoimanine and to its combinations with other antibiotics in experiments in vitro].
    Azimkhodzhaeva MN
    Mikrobiol Zh; 1966; 28(4):63-7. PubMed ID: 5995738
    [No Abstract]   [Full Text] [Related]  

  • 32. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 34. In-vitro activity of lysostaphin. Bioassay in serum.
    Jones DN; Quinn EL; Cox F
    Henry Ford Hosp Med J; 1968; 16(3):235-8. PubMed ID: 5743545
    [No Abstract]   [Full Text] [Related]  

  • 35. Design of a polypeptide FRET substrate that facilitates study of the antimicrobial protease lysostaphin.
    Bardelang P; Vankemmelbeke M; Zhang Y; Jarvis H; Antoniadou E; Rochette S; Thomas NR; Penfold CN; James R
    Biochem J; 2009 Mar; 418(3):615-24. PubMed ID: 19032148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the antistaphylococcal activity of antibiotics].
    Tomimatsu S
    Kumamoto Igakkai Zasshi; 1967 Apr; 41(4):349-76. PubMed ID: 6072783
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of the antibacterial activity and chemical structure of chalcone derivatives.
    Gábor M; Sallai J; Széll T; Sipos G
    Acta Microbiol Acad Sci Hung; 1967; 14(1):45-64. PubMed ID: 6051516
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiphage activity of streptothricins A, B, C, D and F].
    Germanova KI; Goncharskaia TIa
    Antibiotiki; 1969 Feb; 14(2):137-40. PubMed ID: 5768798
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pristinamycin and the bacteriopause phenomenon].
    Videau D
    Ann Inst Pasteur (Paris); 1965 May; 108(5):602-22. PubMed ID: 5838640
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of antibiotics salvin and cansatin on pyogenic cocci].
    Mishenkova EL
    Mikrobiol Zh; 1965; 27(2):45-8. PubMed ID: 5869330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.